SCHEMBL4391635

SCHEMBL4391635

CCOc1ccc(Br)cc1C(=O)C=CN1CCN(c2ccncc2)CC1.COc1cc(C(=O)C=CN2CCN(c3ccncc3)CC2)ccc1OCc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.43
LMNA P02545 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPT P10636 2/20 0.43
USP2 O75604 1/20 0.43
MAPK1 P28482 1/20 0.43
HSD17B10 Q99714 1/20 0.43
RAB9A P51151 2/20 0.43
POLB P06746 1/20 0.43
HPGD P15428 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
TNFRSF1A P19438 2/20 0.42
KDM4E B2RXH2 2/20 0.42
GAA P10253 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
ALOX15 P16050 1/20 0.42
LRRK2 Q5S007 4/20 0.41
DRD3 P35462 1/20 0.40
APP P05067 2/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4376027 0.89 NPC1 (0.53) NPC1LMNAALDH1A1MAPTUSP2
SCHEMBL4378240 0.86 AR (0.44) LMNAALDH1A1MAPTMAPK1HSD17B10
SCHEMBL4391637 0.76 APP (0.60) LMNAHPGDSMN1; SMN2KDM4EAPP
SCHEMBL4382276 0.72 NPC1 (0.55) NPC1LMNAALDH1A1MAPTUSP2
SCHEMBL4378352 0.72 ALDH1A1 (0.57) NPC1LMNAALDH1A1MAPTUSP2
SCHEMBL4376233 0.71 TSHR (0.51) NPC1LMNAALDH1A1MAPTUSP2
SCHEMBL4379194 0.71 ALDH1A1 (0.59) NPC1LMNAALDH1A1MAPTUSP2
SCHEMBL14190919 0.70 APP (0.74) HPGDSMN1; SMN2KDM4EAPPMEN1
SCHEMBL4376030 0.70 APP (0.74) HPGDSMN1; SMN2KDM4EAPPMEN1
SCHEMBL2830259 0.70 NPC1 (0.60) NPC1LMNAALDH1A1MAPTUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1421071-B1 SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS HIGH POINT PHARMACEUTICALS LLC (US) 2009-11-18 EP claimed